XML 26 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Operating activities:      
Net income $ 871,142,000 $ 1,183,370,000 $ 411,778,000
Adjustments to reconcile net income to net cash provided from operating activities:      
Deferred income tax expense (benefit) 227,654,000 215,772,000 (17,727,000)
Depletion, depreciation and amortization and impairment of proved properties 350,165,000 353,420,000 364,555,000
Abandonment and impairment of unproved properties 46,359,000 28,608,000 7,206,000
Derivative fair value (income) loss (821,154,000) 1,188,506,000 650,216,000
Cash settlements on derivative financial instruments 253,514,000 (1,190,154,000) (520,013,000)
Divestiture contract obligation 99,595,000 69,766,000 20,340,000
Allowance for bad debt 0 (250,000) 200,000
Amortization of deferred financing costs and other 4,735,000 7,959,000 8,347,000
Deferred and stock-based compensation 67,849,000 107,959,000 110,356,000
Gain on the sale of assets (454,000) (409,000) (701,000)
(Gain) loss on early extinguishment of debt (438,000) 69,493,000 98,000
Changes in working capital:      
Accounts receivable 223,081,000 (3,286,000) (250,538,000)
Prepaid and other (1,285,000) (18,438,000) (1,140,000)
Accounts payable (77,057,000) 17,077,000 39,231,000
Accrued liabilities and other (265,814,000) (164,649,000) (29,260,000)
Net cash provided from operating activities 977,892,000 1,864,744,000 792,948,000
Investing activities:      
Additions to natural gas and oil properties (571,819,000) (456,505,000) (393,478,000)
Additions to field service assets (701,000) (682,000) (1,231,000)
Acreage purchases (34,410,000) (30,885,000) (23,962,000)
Proceeds from disposal of assets 872,000 518,000 303,000
Purchases of marketable securities held by the deferred compensation plan (45,168,000) (43,691,000) (30,806,000)
Proceeds from the sales of marketable securities held by the deferred compensation plan 49,521,000 41,413,000 31,295,000
Net cash used in investing activities (601,705,000) (489,832,000) (417,879,000)
Financing activities:      
Borrowings on credit facilities 185,000,000 972,000,000 1,434,000,000
Repayments on credit facilities (204,000,000) (953,000,000) (2,136,000,000)
Issuance of senior notes 0 500,000,000 600,000,000
Repayment of senior or senior subordinated notes (60,934,000) (1,659,422,000) (63,324,000)
Dividends paid (77,241,000) (38,638,000) 0
Treasury stock purchases (19,042,000) (399,699,000) 0
Debt issuance costs 0 (16,176,000) (8,854,000)
Taxes paid for shares withheld (39,481,000) (25,492,000) (9,299,000)
Change in cash overdrafts (23,923,000) 9,071,000 16,493,000
Proceeds from the sales of common stock held by the deferred compensation plan 75,201,000 22,229,000 5,879,000
Net cash used in financing activities (164,420,000) (1,589,127,000) (161,105,000)
Increase (decrease) in cash and cash equivalents 211,767,000 (214,215,000) 213,964,000
Cash and cash equivalents at beginning of year 207,000 214,422,000 458,000
Cash and cash equivalents at end of year $ 211,974,000 $ 207,000 $ 214,422,000